A Phase 1 Study to Assess Mass Balance, Pharmacokinetics, and Metabolism of [14C]-Pevonedistat in Patients With Advanced Solid Tumors
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 31 May 2018
At a glance
- Drugs Pevonedistat (Primary) ; Carboplatin; Docetaxel; Paclitaxel
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Takeda Oncology
- 25 May 2018 Planned End Date changed from 3 May 2018 to 30 Sep 2018.
- 25 May 2018 Status changed from recruiting to active, no longer recruiting.
- 25 May 2018 Planned End Date changed from 3 May 2019 to 3 May 2018.